TGA closes investigation into promotion of Dr Thomas Borody’s COVID-19 treatment
The high-profile gastroenterologist has urged GPs to prescribe his ivermectin-based regimen
The TGA has closed its inquiry into the promotion of an ivermectin-based regimen as a potential treatment for COVID-19.
Last year Dr Thomas Borody, the inventor of triple therapy for H. pylori and a pioneer of faecal transplant therapy, had called on GPs to consider prescribing a triple therapy of ivermectin, doxycycline and zinc.
